Skip to content
Recall Observatory FDA recall evidence

Drug product

Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 9777600, Israel

D-0705-2017

April 24, 2017

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 77109
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0705-2017

Official wording

Reason: Microbial Contamination of Non-Sterile Products

Code information: 100 (NDC 0093-4359-01) and 500 count bottles (NDC 0093-4359-05)- Lot # 07C160; Exp. 03/18 100 Unit Dose Blisters/Carton (NDC 0093-4359-93) and Individual Blister Pack (NDC 0093-4359-19) - Lot # 07C160A; Exp. 03/18

Distribution pattern: Nationwide

Derived failure modes

  • Microbial contamination

    reason.microbial_contamination · v1.0.0

    Microbial Contamination